Shanghai Rightongene (China) Market Value

688217 Stock   20.89  0.14  0.67%   
Shanghai Rightongene's market value is the price at which a share of Shanghai Rightongene trades on a public exchange. It measures the collective expectations of Shanghai Rightongene Biotechnology investors about its performance. Shanghai Rightongene is trading at 20.89 as of the 1st of December 2024, a 0.67% up since the beginning of the trading day. The stock's open price was 20.75.
With this module, you can estimate the performance of a buy and hold strategy of Shanghai Rightongene Biotechnology and determine expected loss or profit from investing in Shanghai Rightongene over a given investment horizon. Check out Shanghai Rightongene Correlation, Shanghai Rightongene Volatility and Shanghai Rightongene Alpha and Beta module to complement your research on Shanghai Rightongene.
Symbol

Please note, there is a significant difference between Shanghai Rightongene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shanghai Rightongene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shanghai Rightongene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Shanghai Rightongene 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Shanghai Rightongene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Shanghai Rightongene.
0.00
09/02/2024
No Change 0.00  0.0 
In 3 months and 1 day
12/01/2024
0.00
If you would invest  0.00  in Shanghai Rightongene on September 2, 2024 and sell it all today you would earn a total of 0.00 from holding Shanghai Rightongene Biotechnology or generate 0.0% return on investment in Shanghai Rightongene over 90 days. Shanghai Rightongene is related to or competes with PetroChina, China Mobile, CNOOC, Ping An, China Petroleum, China Telecom, and China State. Shanghai Rightongene is entity of China. It is traded as Stock on SHG exchange. More

Shanghai Rightongene Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Shanghai Rightongene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Shanghai Rightongene Biotechnology upside and downside potential and time the market with a certain degree of confidence.

Shanghai Rightongene Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Rightongene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Shanghai Rightongene's standard deviation. In reality, there are many statistical measures that can use Shanghai Rightongene historical prices to predict the future Shanghai Rightongene's volatility.
Hype
Prediction
LowEstimatedHigh
16.5821.3626.14
Details
Intrinsic
Valuation
LowRealHigh
11.6316.4121.19
Details
Naive
Forecast
LowNextHigh
15.0519.8324.60
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Shanghai Rightongene Backtested Returns

Shanghai Rightongene appears to be somewhat reliable, given 3 months investment horizon. Shanghai Rightongene owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.15, which indicates the firm had a 0.15% return per unit of risk over the last 3 months. By inspecting Shanghai Rightongene's technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please review Shanghai Rightongene's Risk Adjusted Performance of 0.1147, semi deviation of 3.91, and Coefficient Of Variation of 718.65 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Shanghai Rightongene holds a performance score of 12. The entity has a beta of -0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Shanghai Rightongene are expected to decrease at a much lower rate. During the bear market, Shanghai Rightongene is likely to outperform the market. Please check Shanghai Rightongene's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Shanghai Rightongene's existing price patterns will revert.

Auto-correlation

    
  0.84  

Very good predictability

Shanghai Rightongene Biotechnology has very good predictability. Overlapping area represents the amount of predictability between Shanghai Rightongene time series from 2nd of September 2024 to 17th of October 2024 and 17th of October 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Shanghai Rightongene price movement. The serial correlation of 0.84 indicates that around 84.0% of current Shanghai Rightongene price fluctuation can be explain by its past prices.
Correlation Coefficient0.84
Spearman Rank Test0.79
Residual Average0.0
Price Variance2.13

Shanghai Rightongene lagged returns against current returns

Autocorrelation, which is Shanghai Rightongene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Shanghai Rightongene's stock expected returns. We can calculate the autocorrelation of Shanghai Rightongene returns to help us make a trade decision. For example, suppose you find that Shanghai Rightongene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Shanghai Rightongene regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Shanghai Rightongene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Shanghai Rightongene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Shanghai Rightongene stock over time.
   Current vs Lagged Prices   
       Timeline  

Shanghai Rightongene Lagged Returns

When evaluating Shanghai Rightongene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Shanghai Rightongene stock have on its future price. Shanghai Rightongene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Shanghai Rightongene autocorrelation shows the relationship between Shanghai Rightongene stock current value and its past values and can show if there is a momentum factor associated with investing in Shanghai Rightongene Biotechnology.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.